STEPHEN QUARTERMAN: Open Payments
NPI 1427100254 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 58 payments from 16 companies in 2025. Trend: 2023 $1,661 · 2024 $1,569 · 2025 $1,151
Food & beverage: $1,045Education: $106
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $255 |
| Regeneron Healthcare Solutions, Inc. | 10 | $214 |
| ABBVIE INC. | 8 | $152 |
| UCB, Inc. | 10 | $144 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $63 |
| Incyte Corporation | 2 | $50 |
| Biofrontera Inc. | 2 | $43 |
| PFIZER INC. | 2 | $37 |
| Organon LLC | 1 | $28 |
Products named: TREMFYA, DUPIXENT, Bimzelx, RINVOQ, ILUMYA, OPZELURA, COSENTYX, AMELUZ.
Industry payments across SC — which companies pay providers there.
